CRISPR/Cas9 technology introduced a glutamate to valine substitution at residue 85 (E85V). This line was generated from founder 2. (J:306883)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count